Press release
Niemann-Pick Disease Type C Market Growth with MIPLYFFA, Gene Therapy & Regulatory Advances | Zevra Therapeutics, IntraBio, and Johnson & Johnson Services, Inc.
Niemann-Pick Disease Type C
The Niemann Pick Disease Type C (NPC) Market is led by key innovators like Zevra Therapeutics, IntraBio, and Johnson & Johnson Services, Inc., delivering breakthrough orphan therapies as per our analysis. These companies, along with emerging players in gene therapy, are progressing treatments like MIPLYFFA® (arimoclomol), IB1001 (N-Acetyl-L-Leucine), and other pipeline candidates, supported by recent FDA approvals and evolving rare-disease infrastructure.
Download your exclusive sample report today: https://www.datamintelligence.com/download-sample/niemann-pick-disease-type-c-market?jd
Niemann Pick Disease Type C Market M&A & Strategic Collaborations
1. Zevra Therapeutics sold its FDA Priority Review Voucher for $150 M to fund MIPLYFFA® commercialization and future R&D.
2. Zevra announced long-term efficacy & safety results for MIPLYFFA®, reinforcing its market position and commercial viability.
3. IntraBio's IB1001 (N-Acetyl-L-Leucine) maintains orphan and fast-track designations, supporting its pipeline status as a neuroprotective candidate.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/niemann-pick-disease-type-c-market?jd
Key Growth Drivers & Emerging Opportunities in the Niemann Pick Disease
Type C Market
1. Rapid market expansion: from USD 9 M in 2024 to USD 923.6 M by 2033, CAGR of 28.9%.
2. FDA approvals for arimoclomol and levacetylleucine (2024) establish treatment standards.
3. Peer-reviewed long-term data support efficacy and safety in NPC patients, aiding adoption.
4. Emerging neuroprotective oral therapies (e.g., IB1001) expand the indication scope and patient access.
5. Significant orphan-drug incentives and PRV monetization strengthen R&D investment and commercial strategies.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=niemann-pick-disease-type-c-market?jd
Regional Market Drivers in the Niemann Pick Disease Type C Market
North America leads with the largest diagnosed patient pool, strong reimbursement policies, and early adoption.
Europe accelerates growth via orphan designations, country-level NPC registries, and multisite trials.
Asia-Pacific is emerging with increasing genetic screening programs and expanding rare disease networks.
Latin America & MEA are building awareness, diagnosis, and rare disease treatment infrastructure.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?jd
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Niemann-Pick Disease Type C Market Growth with MIPLYFFA, Gene Therapy & Regulatory Advances | Zevra Therapeutics, IntraBio, and Johnson & Johnson Services, Inc. here
News-ID: 4113865 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
North America Vaginal Health Probiotic Supplements Market to Double, Reaching $2 …
The North America vaginal health probiotic supplements market reached US$111.93 million in 2024 and is expected to reach US$225.99 million by 2032, growing at a CAGR of 9.3% during the forecast period 2025-2032.The market is growing rapidly, fueled by rising awareness of women's intimate health and the increasing prevalence of vulvovaginal discomfort. A US survey of 913 women found that 79.1% were diagnosed with genitourinary syndrome of menopause (GSM), with…
United States Silicon Drift Detectors Market Insights 2025: High-Resolution Imag …
The Global Silicon Drift Detectors Market is predicted to reach at a CAGR of 5.1% during the forecast period 2024-2031.
Silicon Drift Detectors (SDDs) are advanced semiconductor-based radiation detectors that utilize a unique lateral charge drift mechanism to achieve high energy resolution and fast response times. They are widely employed in applications requiring precise X-ray spectroscopy, such as medical imaging, industrial inspection, and scientific research. SDDs offer improved performance over traditional…
United States Data Lakes Market to Grow at 20.6% CAGR Through 2031, Driven by AI …
Global Data Lakes Market is estimated to grow at a CAGR Of 20.6% during the forecast period 2024-2031.
The data lakes market encompasses platforms that enable organizations to store vast amounts of structured and unstructured data in its raw form. These systems facilitate advanced analytics, machine learning, and real-time data processing. By consolidating diverse data sources, data lakes support scalable and cost-effective data management solutions.
Their flexibility and integration capabilities make them…
United States & Japan Semiconductor Developments: Investments, Research, and Sup …
The Global Semiconductors Market reached US$ 640.6 billion in 2022 and is expected to reach US$ 1,132.8 billion by 2031, growing with a CAGR of 7.5% during the forecast period 2024-2031. The Global Semiconductors Market is a vital and rapidly evolving industry that plays a fundamental role in various sectors of the global economy.
The semiconductor market encompasses the design, manufacturing, and sale of semiconductor devices, which are essential components…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
